Democratize access to scientific data and promote collaboration for the well-being of ecosystems.

Gencovery was founded by two applied-mathematics researchers, graduates of École Centrale de Nantes (Djomangan Adama OUATTARA, PhD) and École polytechnique (Wassim ABOU-JAOUDE, PhD). The company is supported by the BIOASTER Technological Research Institute and incubated by SATT PULSALYS and LifeHub Lyon (Bayer).

Gencovery deployed the first prototype of its Constellab™ digital platform and signed its first contract with Bayer in Lyon (France).

Constellab™ is used in R&D to deepen the understanding of microorganism biology — combining AI and digital twins — to design safer and more effective crop-protection products.

Product deployment: Constellab™ launches on OVHcloud and is adopted by Adisseo for animal-nutrition R&D.

Support & community: the Constellab™ Community platform delivers documentation to better support our customers.

R&D & partnerships: winner of the R&D Booster 2022 call funded by Auvergne-Rhône-Alpes and Bpifrance; Gencovery–Greencell–BIOASTER partnership for 2nd-generation digital twins to reinforce bioprocesses through AI.

Ecosystem & events: successful 1st edition of Constellab Connect, focused on digital modeling of microbial communities in life sciences and health.

Product & adoption: launch of Constellab™ v1; a robust Customer Success process is established.

Deployment: Constellab™ ships on Microsoft Azure and on-premise; partnership signed with Beckman-Coulter to drive lab instruments directly from Constellab™.

Strategic collaborations: with SupBiotech on AI and bioinformatics training; with Institut Imagine (AP-HP) to apply digital twins to the metabolic mechanisms of rare genetic diseases.

AI capabilities: generative AI integrated to simplify data exploration and visualization for biologists.

Ecosystem & events: successful 2nd edition of Constellab Connect, focused on AI in biotech and health.

US exploration: co-organizer of the 8th Boston Biotech Summit; market and investor exploration in the United States.

Sector leadership: chairing a Data/AI working group with AFSSI (Association Française des Sociétés de Service et d'Innovation in life sciences; 130+ CRO companies in France).

Openness & community: launch of the Fair Open Access offer via the Constellab Community platform.

Funding: first crowdfunding bridge round with targets exceeded by >150%; launch of the second round.

Flagship event: successful 3rd edition of Constellab Connect, focused on real-world data (RWD) interoperability for innovation and care.

Commercial restructuring: we reshape our go-to-market to reduce CAC, limiting bespoke services in order to refocus on selling and industrializing Constellab.

Mature, market-ready product: Constellab can be deployed autonomously by customers, with a simplified experience for every profile, including non-data users.

Validated go-to-market: a formalized, proven commercial process; Constellab is positioned as a platform to design and deploy immediately useful business apps; referral-driven acquisition, smooth demos via Community, and focus on clear, actionable business dashboards.

Sales-aligned internal organization: technical teams oriented toward "business specifications" and AI packaging; application engineers in the field; project-management upskilling.

Activated ecosystem: structuring partnerships (clusters, business parks), customer workshops and collaborations with freelancers/integrators to accelerate use cases.

Reinforced marketing: Community evolving toward a marketplace, clarified website, white-paper publication; refocusing on field sales over events.

Sales: strong acceleration, with a €500k target (service + product); need to further automate commercialization and accelerate delivery, which favors selling ready-made business modules. Four generic modules have been identified, covering most companies' needs; their relevance is being validated through first sales.

Constellab Edge: formalization of the offer born from our partnership with Beckman Coulter — deploying preconfigured Constellab instances with ready-made business apps at customer sites (turn-key, on-premise).

Gencovery formalizes its societal commitment by becoming a Mission-driven company (Entreprise à Mission), anchoring its contribution to more open, collaborative and sovereign life-sciences research.

CROPulse brings together a consortium of academic and industrial partners to accelerate innovation in crop protection through the Constellab™ platform and digital twins.

Financial goal: reach financial break-even.

Scale-up & Marketplace: Gencovery now has the full technological infrastructure to scale its business model. Constellab Community becomes a trusted digital exchange platform to value data and innovative services in life sciences and health, built around: a network of Constellab digital labs already being deployed at customers'; a blockchain layer for trust, traceability and monetization; an active community (creators, integrators, customers) that is curated and contributive; and ready-to-use business modules that help companies — primarily CROs — streamline their R&D, production and commercialization activities through Constellab.